Sanofi (SNYNF, SNY) said that the U.S. Food and Drug Administration has updated the label for FLUBLOK (Influenza Vaccine) to include ...
The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza ...
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...
"Today, we're proud to announce an important update to our label for FLUBLOK, from one of Sanofi's largest flu vaccine safety studies ever done in pregnant individuals, an important at-risk ...
France considers blocking Sanofi's $16 billion consumer division sale to U.S. firm CD&R, citing concerns over healthcare ...
Recent health news highlights include WHO's approval of an mpox vaccine for adolescents, $1 billion in WHO budget pledges, ...
Clesrovimab scored on several endpoints, showing an ability to protect infants against the virus in their first RSV season.
Sanofi launches high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK · Developed with a higher antigen content to increase protection in older adults, a population at greater ...
This summary highlights global health-related news, including the WHO's approval of a vaccine for adolescents, France seeking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback